APA

Madayag R. M., Johnson L. B., Bartlett S. T., Schweitzer E. J., Constantine N. T., McCarter R. J., Kuo P. C., Keay S. & Oldach D. W. (19980122). Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease. : Transplantation.

Chicago

Madayag R M, Johnson L B, Bartlett S T, Schweitzer E J, Constantine N T, McCarter R J, Kuo P C, Keay S and Oldach D W. 19980122. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease. : Transplantation.

Harvard

Madayag R. M., Johnson L. B., Bartlett S. T., Schweitzer E. J., Constantine N. T., McCarter R. J., Kuo P. C., Keay S. and Oldach D. W. (19980122). Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease. : Transplantation.

MLA

Madayag R M, Johnson L B, Bartlett S T, Schweitzer E J, Constantine N T, McCarter R J, Kuo P C, Keay S and Oldach D W. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease. : Transplantation. 19980122.